Evidence map›Paper›PMID 39924980›Full record

ArticleCNS neuroscience & therapeutics2025

Low-Frequency Stimulation at the Ventromedial Hypothalamus Exhibits Broad-Spectrum Efficacy Across Models of Epilepsy.

Shuang Zou, Yiwei Gong, Mengqi Yan, Zhijian Yuan, Minjuan Sun, Shuo Zhang, Yuanzhi Yang, Xiongfeng Guo, Lan Huang, Fan Fei and 3 more

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shuang ZouZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Yiwei GongZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Mengqi YanZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zhijian YuanZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Minjuan SunZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Shuo ZhangZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Yuanzhi YangZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Xiongfeng GuoZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Lan HuangZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Fan FeiZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Yi WangZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-1350-2961
Zhong ChenZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0003-4755-9357
Cenglin XuZhejiang Key Laboratory of Neuropsychopharmacology, the Second Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Xinhua Hospital), School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-4337-3777

Funding

National Natural Science Foundation of China 82173796National Natural Science Foundation of China 82330116National Natural Science Foundation of China 82374064the Research Project of Zhejiang Chinese Medical University 2023JKZDZC04
6 · The paper itself

Abstract

aimsThe limited efficacy and very restricted antiseizure range of current deep brain stimulation (DBS) targets highlight the need to find an optimal target for managing various seizure types. Here, we aimed to investigate the efficacy of DBS on the ventromedial hypothalamus (VMH) in the different types of experimental epileptic seizures.

methodsThe efficacy of DBS was examined in various epileptic seizure models, and the potential mechanisms were investigated by using in vivo calcium signal recording and optogenetics.

resultsThe c-fos expression was significantly increased in the glutamatergic neurons of VMH (VMH

conclusionThese findings demonstrate that VMH-LFS is a broad-spectrum treatment approach for different seizure types by decreasing VMH

Indexed as

Deep Brain StimulationEpilepsyVentromedial Hypothalamic NucleusAnimalsDisease Models, AnimalKainic AcidMaleMiceMice, Inbred C57BLOptogeneticsPentylenetetrazoleRatsRats, Sprague-DawleySeizuresKainic AcidPentylenetetrazoleepilepsylow‐frequency stimulationseizureventral medial hypothalamus

Identifiers

PMID39924980
PMCPMC11808192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.